Trapping of a catalytic HIV reverse transcriptase·template:primer complex through a disulfide bond  by Huang, Huifang et al.
Trapping of a catalytic HIV reverse transcriptase•template:primer
complex through a disulfide bond
Huifang Huang1*, Stephen C Harrison2 and Gregory L Verdine1
Background: HIV-1 reverse transcriptase (RT) is a major target for the
treatment of acquired immunodeficiency syndrome (AIDS). Resistance
mutations in RT compromise treatment, however. Efforts to understand the
enzymatic mechanism of RT and the basis for mutational resistance to anti-RT
drugs have been hampered by the failure to crystallize a catalytically informative
RT–substrate complex.
Results: We present here experiments that allow us to understand the reason
for the failure to crystallize such a complex. Based on this understanding, we
have devised a new approach for using a combinatorial disulfide cross-linking
strategy to trap a catalytic RT•template:primer•dNTP ternary complex, thereby
enabling the growth of co-crystals suitable for high-resolution structural
analysis. The crystals contain a fully assembled active site poised for catalysis.
The cross-link itself appears to be conformationally mobile, and the surrounding
region is undistorted, suggesting that the cross-link is a structurally passive
device that merely acts to prevent dissociation of the catalytic complex. 
Conclusions: The new strategy discussed here has resulted in the
crystallization and structure determination of a catalytically relevant
RT•template:primer•dNTP complex. The structure has allowed us to analyze
possible causes of drug resistance at the molecular level. This information will
assist efforts to develop new classes of nucleoside analog inhibitors, which
might help circumvent current resistance profiles. The covalent trapping
strategy described here may be useful with other protein–DNA complexes that
have been refractory to structural analysis.
Introduction
The reverse transcriptase (RT) enzyme of the human
immune deficiency virus (HIV) catalyzes the multistep
conversion of the single-stranded viral RNA genome into
a double-stranded DNA copy, which then integrates into
the host genome [1,2]. Because of its central function in
HIV proliferation, RT is a major target for therapeutic
agents that combat HIV infection [3,4]. In the United
States, seven RT inhibitors are currently licensed as
drugs. On the basis of their mechanism of action, RT
inhibitors are divided into two groups: non-nucleosides
and nucleoside analogs. Non-nucleoside inhibitors are
diverse in terms of chemical structure, but all bind to a
common hydrophobic pocket in RT adjacent to the poly-
merase active site. Nucleoside analog inhibitors are pro-
drugs, which are converted into the active form, the
5′-triphosphate, by cellular enzymes. As a class, the nucle-
oside analog inhibitors lack the 3′-hydroxyl groups
required for chain extension, and their incorporation by
RT results in chain termination.
Development of resistance through mutations in RT seri-
ously limits the long-term effectiveness of these drugs
[5,6]. There is, therefore, widespread interest in under-
standing the mechanisms of resistance as a step toward
developing more effective treatments for HIV infection.
Structures have been available since 1993 for RT holoen-
zyme, RT complexed with a duplex DNA alone, and RT
bound to a non-nucleoside inhibitor [7–14]. Until recently,
however, attempts to understand the catalytic mechanism
of RT and the influence of mutations on the enzyme have
been hampered by the lack of a three-dimensional struc-
ture for the catalytic complex formed between RT, a tem-
plate:primer, and a nucleotide triphosphate. The earlier
structures yielded valuable insights into the overall archi-
tecture of the enzyme and provided a basis for understand-
ing the mechanism underlying development of resistance
to non-nucleoside inhibitors, but they left open key ques-
tions regarding the interaction of RT with an incoming
nucleotide and with the template overhang. Moreover, the
structures suggested, paradoxically, that many mutations
that cause resistance to nucleoside analogs are located far
outside the enzyme reactive site, leaving no obvious ratio-
nale for their effects on the enzyme. Resolution of this
paradox is a pre-requisite for applying a rational approach
to the development of new nucleoside analog drugs.
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Despite concerted efforts in several laboratories, it has
thus far not been possible to obtain high-quality co-crys-
tals of RT bound noncovalently to a template:primer and
a nucleoside triphosphate using conventional approaches.
We describe here a biochemical analysis of RT–substrate
binding that suggests that the previous inability to crystal-
lize a noncovalent ternary complex resulted from insuffi-
cient specificity of RT for a polymerizable end in DNA.
To channel the multiple equilibrating RT–substrate com-
plexes into a homogenous catalytically relevant species,
we have developed a strategy by which the enzyme is
covalently cross-linked to the template:primer. An impor-
tant aspect of this strategy is the choice of disulfide bond
formation as the cross-linking chemistry, which allows the
cross-link to be generated under equilibrium conditions,
thereby avoiding kinetic trapping of strained or transient
species. Using this approach, we have succeeded in crys-
tallizing a catalytically relevant RT•template:primer•
dNTP complex. The 3.2 Å structure of this complex has
revealed a large domain shift that brings the residues
responsible for resistance to nucleoside analog inhibitors
close to the enzyme active site ([15]; PDB code 1RTD).
The structure also revealed that the single-stranded
portion of the template does not pass through a cleft near
the active site as previously believed, but rather runs
alongside the surface of the enzyme [15]. The detailed
biochemical description of RT–DNA cross-linking pro-
vided here reveals that the cross-linking chemistry is
remarkably sensitive to even subtle differences in the rel-
ative positions of the two reacting partners. The conclu-
sion is reinforced by analysis of an extension of the
cross-linking strategy to include disulfide trapping of RT
on an RNA:DNA heteroduplex template:primer. Our
detailed biochemical studies provide a blueprint for use of
disulfide cross-linking in structural analysis of other chal-
lenging protein–nucleic acid complexes.
Results
Overexpression strategy 
To facilitate the high-level overexpression and subsequent
purification of wild-type and mutant RT enzymes, we con-
structed a new Escherichia coli overexpression system in
which the two RT subunits, p66 and p51, are biosynthe-
sized simultaneously. The coding sequences for both p66
and p51, each linked to an independent T7 promoter,
were introduced into the plasmid pLM1 [16,17] oriented
in opposite directions. A His6 tag was attached at the car-
boxyl terminus of p51, to enable separation by Ni-NTA
chromatography of homogenous RT heterodimer contain-
ing full-length p51 from the heterogeneous heterodimer
that can arise from intracellular proteolysis of the p66•p66
homodimer. An additional advantage of encoding p66 and
p51 independently, as opposed to relying on intracellular
proteolysis of p66, is that it allows mutations to be made in
a particular subunit. In our hands, the co-expression
system routinely yields ~1 mg/l of highly purified RT.
Electrophoretic mobility shift assay (EMSA)
In an attempt to understand the reason for the failure to
co-crystallize a noncovalent ternary RT•template:
primer•dNTP complex, we decided to analyze the robust-
ness of this complex using EMSA in a competition format.
RT was briefly incubated with a radiolabeled polymeriz-
able substrate (i.e. a duplex oligonucleotide that has a
recessed 3′-end, Figure 1a). To this was added varying
amounts of a nonpolymerizable competitor (i.e. a duplex
oligonucleotide that has 3′-overhangs, Figure 1a). After
allowing sufficient time for the establishment of equilib-
rium, the reaction mixture was run on a nondenaturing
polyacrylamide gel to separate the RT-bound substrate
from unbound substrate. This procedure was carried out
in the absence of added nucleotide — a condition in
which no polymerization takes place — and in the pres-
ence of ddCTP — a condition in which one cycle of poly-
merization takes place and an additional ddCTP molecule
can bind noncovalently to the terminated RT•template:
primer complex (Figure 1a).
In the absence of nucleotide, the nonpolymerizable DNA
competed on a equal basis with the radiolabeled polymer-
izable substrate (Figure 1b); for example, addition of one
mole equivalent of competitor reduced the intensity of
the RT–substrate band by 50%, and addition of 25 equiva-
lents reduced the intensity to 4% of the starting value. In
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Figure 1
Analysis of affinity and specificity of RT–DNA substrate interaction
using an electrophoretic mobility shift assay (EMSA). (a) Sequences of
DNA substrate and competitor used in this study. (b,c) Competition
assay of RT–DNA substrate interaction by increasing amounts of DNA
competitor, as analyzed by nondenaturing polyacrylamide gel, in (b) the
absence or (c) the presence of ddCTP.
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the absence of nucleotide, therefore, RT shows no dis-
crimination between a polymerizable DNA substrate and
a nonpolymerizable competitor.
When ddCTP was added to the RT–substrate mixture,
the ability of the nonpolymerizable DNA to compete was
dramatically reduced (Figure 1b). For example, addition
of a 25 equivalents of competitor over substrate resulted in
only 44% reduction in the intensity of the RT•substrate
complex. Taking into account all of the data in Figure 1b,
we conclude that RT shows 6–10-fold preference to bind a
polymerizable substrate over a nonpolymerizable one, in
the presence of a terminating nucleotide co-substrate.
Encouraged by this result, we conducted extensive crys-
tallization trials under nucleotide-addition conditions mir-
roring these used in EMSA, but the only crystals obtained
did not contain DNA (data not shown). We therefore con-
cluded that in the case of RT, 6–10-fold specificity is
insufficient to produce a complex suitable for crystalliza-
tion. We imagine that, with this limited level of speci-
ficity, there exist multiple equilibrating RT•substrate
complexes under the conditions of crystallization, and this
inhomogeneity impedes co-crystal formation.
Strategy of disulfide cross-linking
Because the main problem appeared to be that RT and its
co-substrates associate to form a heterogeneous mixture of
complexes, we sought a means of channeling these into a
single homogenous complex representing a catalytically
relevant species. Covalent cross-linking seemed to repre-
sent an attractive possibility. Implementing such an
approach is complicated, however, by the undesirable pos-
sibility of kinetically trapping a strained or otherwise cat-
alytically irrelevant species. To avoid this problem, we
elected to use an equilibrium (kinetically reversible) cross-
linking scheme, in which the noncovalent interactions
between RT and its co-substrates would dictate the forma-
tion of a covalent cross-link. In evaluating the various
chemistries available for equilibrating cross-linking of RT
to its template:primer, we chose disulfide bond formation,
for the following reasons:  the reaction through which
disulfide bonds are formed, thiol-disulfide interchange,
proceeds readily under physiological conditions [18,19];
disulfide bond formation is a mild and reversible chemical
process, especially in the presence of a thiol reducing
agent; and efficient chemistry exists for the site-specific
attachment of tethered thiols into DNA [20–22]. Further-
more, thiol-bearing cysteine residues can be readily intro-
duced into a protein through site-directed mutagenesis.
Selecting the positions of cross-link attachment in DNA
and RT required an approximate notion of what base
pairs and residues might lie near one another in the cat-
alytic complex. Although there existed insufficient infor-
mation to predict proximity with certainty, a hypothesis
was presented by a published model [23] based on the
crystal structure of RT•duplex DNA complex [8],
together with the results of alanine-substitution metagen-
esis and energy-minimized calculations. This model pro-
posed that amino acid residues positioned along one face
of α-helix H in the RT p66 subunit (Gln258, Gly262 and
Trp266) track along the minor groove of the
template:primer. We reasoned that a cysteine residue
introduced into this face of helix H should reach toward
the ‘floor’ of the minor groove, where it could react with a
thiol-bearing tether protruding from the minor groove
floor toward helix H, thereby forming a disulfide cross-
link and trapping the RT•DNA complex (Figure 2). To
explore this possibility, we generated three variant RT
proteins (Gln258→Cys-RT [Q258C-RT], Gly262→Cys-
RT [G262C-RT], and Trp266→Cys-RT [W266C-RT],
respectively) that have cysteine residues engineered indi-
vidually into successive turns of helix H. At the same
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Figure 2
Chemistry of disulfide bond formation. When
appropriately aligned, the sidechain of an
engineered cysteine residue (blue) in helix H
(gold) of RT can react to a thiol group in the
minor groove of DNA (activated as the mixed
disulfide) to form a disulfide bond. The thiol
group is tethered to N2 of a dG (green) in the
template:primer.
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time, we used convertible nucleoside methodology [22] to
introduce a thiol tether into the minor groove of DNA at
the N2-position of a guanine residue (N2-G; refer to
Figure 2) located several residues away from the recessed
3′-end of the template:primer.
Taking into account the possibility that this model might
deviate in certain details from the actual RT–DNA inter-
action, and expecting that the cross-linking reaction would
be sensitive to factors of geometry and distance between
the reacting partners, we devised a limited combinatorial
approach whereby multiple potential cross-link configura-
tions could be sampled (Figure 3a). We designed a tem-
plate:primer that would allow defined cycles of
polymerization followed by termination to be carried out
simply by appropriate choice of terminating and nontermi-
nating nucleotides. In this way, the enzyme could be
‘ratcheted’ forward on the template:primer one base pair
at a time, while holding fixed position of the reactive thiol
in DNA. Additional variations could be gained by trans-
posing the location of the engineered cysteine along helix
H, by tethering the reacting thiol in either the template
strand or the primer strand, and by varying the tether
length in DNA (Figure 2, n = 2 or 3).
Combinatorial cross-linking analysis
The various permutations of cysteine-mutant RT,
extended/terminated template:primer, location of the
tether, and tether length were analyzed for their ability
to undergo cross-linking using denaturing polyacry-
lamide gel electrophoresis (Figures 3b,4a). The p51 and
p66 subunits of RT are sufficiently different in size that
they are clearly resolved by sodium dodecyl
sulfate–polyacylamide gel electrophoresis (SDS–PAGE).
Covalent linkage of either subunit to DNA would be
expected to result in a loss of band intensity for that
subunit, accompanied by the appearance of a new band
that has retarded mobility, owing to the presence of an
attached DNA strand. The results with the thiol group
tethered in the template strand have been reported pre-
viously [15], and are reproduced here for completeness,
as part of comprehensive analysis of the factors influenc-
ing cross-linking efficiency.
The analysis begins with a template:primer having a thiol
group attached to the template strand (DNA T,
Figure 3a). As indicated in the upper-left panel of
Figure 3b, following one cycle of polymerization (+1 lane),
no cross-linking was observed; nor was any observed after
two cycles (+2). After three cycles of polymerization (+3),
however, roughly half of the p66 subunit was found to be
cross-linked to DNA. One further cycle of polymerization
(+4) resulted in a complete loss of cross-linking. These
results can be interpreted as follows: after three cycles of
polymerization, the cysteine and DNA-thiol are optimally
positioned to react; fewer or further cycles simply move
the reacting partners away from the optimal configuration
(Figure 3c).
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Figure 3
Biochemical studies of RT–DNA cross-linking.
(a) The sequence of the template:primer and
the constituents of the dNTP/ddNTP mixtures
used in this study. Polymerization was initiated
and continued by successive extensions using
dNTPs (cyan), and terminated through
incorporation of a ddNTP (red). An additional
dNTP (blue), present in the reaction mixture,
occupies the active site of RT, pairing with the
corresponding base of the template. A thiol
group is either attached to the –3 dG in the
template strand (DNA T), or attached to the –4
dG in the primer strand (DNA P). (b) SDS gel
analysis of the reactions between the three
cysteine-engineered RT mutants and the thiol-
tethered template:primer under the four
polymerization conditions illustrated in (a). In
the nonreducing PAGE analysis used here with
protein staining, disulfide cross-linking between
the p66 subunit of RT and DNA results in the
appearance of a new band having retarded
mobility (p66–DNA), accompanied by reduced
intensity of the p66 band. Slight difference of
mobility of p66–DNA bands in the left and right
panel of gels probably results from unequal size
of the template strand relative to the primer
strand attached. (c) Representation of the
process leading to efficient cross-linking
between Q258C-RT and DNA. The p66
subunit of RT is represented by the polymerase
structural convention as a right hand (gray).
After two cycles of polymeric reactions (cyan)
and one cycle of termination (red), an additional
dTTP (blue base, magenta for triphosphate)
occupies the active-site pocket formed by the
palm region and part of the finger region of
p66. This configuration optimally positions the
sidechain of Cys258 (blue) in helix H (gold)
relative to the thiol group tethered to the dG
(green) in the template strand, thereby resulting
in efficient disulfide bond formation. The single
stranded part of the template is depicted as
passing by the surface of the finger region,
rather than through the active-site groove as
seen in the structure of
RT•template:primer•dTTP ternary complex [15].
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When the engineered cysteine residue in RT is trans-
posed by one turn along helix H (Figure 3b, left G262C-
RT panel), cross-linking is again positionally selective, but
the highest efficiency of cross-linking now occurs after
two cycles of polymerization. Remarkably, transposition of
the engineered cysteine residue by one additional turn
along helix H results in a further one-base-pair decrease in
the optimal number of polymerization cycles (+1, left
W266C-RT panel). Wild-type RT failed to cross-link the
thiol-tethered template:primer under identical reaction
conditions (Figure 3b, left wild-type panel), even though
this form of the protein contains a cysteine residue on
helix I (p66 C280) within ~5 Å of the DNA backbone. 
When the tethered G was moved from position –3 of the
template strand to position –4 of the primer strand
(DNA P, Figure 3a), cross-linking was also positionally
selective (Figure 3b, right-hand set of panels). Moving the
tether by one base pair along the DNA, however, corre-
spondingly reduced by one cycle the polymerization
required to achieve optimal cross-linking (compare the
paired sets of right-hand and left-hand panels in
Figure 3b). Again, a monotonic decrease in the preferred
number of polymerization cycles was observed as the posi-
tion of the cysteine residue was transposed along succes-
sive turns of helix H, such that the W266C enzyme
overshot its optimal cross-linking target after the addition
of even one nucleotide. Although we did not analyze cross-
linking in the absence of any added nucleotide, it is reason-
able to expect that this will be the preferred cross-linking
configuration for W266C-RT with the primer-tethered sub-
strate. Shifting the tether from template (–3) to primer (–4)
reduced the rate of cross-linking somewhat, as evidenced
by reduced yields of cross-linked product, and therefore we
chose the former for structural studies. 
Taken together, these data demonstrate that the engi-
neered thiol moieties on RT and on the template:primer
participate in disulfide cross-linking, through a reaction
that has exquisite positional selectivity.
Of the multiple cross-link configurations studied here,
Q258C-RT, together with the template-tethered tem-
plate:primer showed the greatest degree of positional
selectivity and highest efficiency in disulfide cross-
linking. This particular configuration was therefore
chosen for further biochemical and structural studies.
Variation of the tether length in DNA
To investigate the dependence of the cross-linking reaction
on the length of the tether in DNA, two template:primers
that have identical sequences (DNA T, Figure 3a), but differ
in whether they possess a C2 or C3 tether (refer to Figure 2,
n = 2 or 3, respectively), were prepared and employed in par-
allel kinetic cross-linking analyses with Q258C-RT. As
shown in Figure 4a, the template:primer with the C3 thiol
tether (bottom panel) undergoes disulfide cross-linking to
the cysteine engineered enzyme at a faster rate than that of
the corresponding template:primer with the C2 linker (top
panel), even though the latter enjoys an entropic advantage,
owing to the presence of fewer rotative bonds in the tether.
Based on these results, the template:primer with a C3 thiol-
bearing tether, together with Q258C-RT, were chosen for
high-resolution structural studies [15].
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Figure 4
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Kinetic studies of covalent complex formation of Q258C-RT with
different template:primers under various conditions, as analyzed by
denaturing SDS–PAGE under nonreducing conditions. (a) Covalent
complex formation of Q258C-RT with a template:primer having either a
C2- or a C3-tethered thiol group in the template strand of DNA.
(b) Covalent complex formation of Q258C-RT with either a DNA:DNA
or RNA:DNA template:primers. (c) Same as the 120 min time point in
(b), except that the reaction was carried out at the presence of
increasing amounts of reducing agent, dithiothreitol (DTT).
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Comparison of disulfide cross-linking to DNA:DNA versus
RNA:DNA template:primers
During the viral life cycle, RT uses both RNA and DNA
templates to program the synthesis of a complementary
DNA copy. It was, therefore, of interest to compare the
structure and activity of RT on both forms of nucleic acid
template. We examined the kinetics of disulfide cross-
linking of Q258C-RT to an RNA versus DNA template.
For this purpose, a thiol-bearing tether was linked to the
N2-position of the corresponding guanine in the RNA
template strand, using chemistry analogous to that
employed in the DNA case [24,25]. As shown in
Figure 4b, Q258C-RT cross-links to the RNA:DNA sub-
strate (bottom panel) at a much faster rate than to the
DNA:DNA substrate (top panel). For example, whereas
the cross-linking reaction is more than 50% complete with
RNA:DNA after 5 minutes, it takes roughly 2 hours to
reach the same level of conversion with DNA:DNA. Fol-
lowing from these preliminary studies, we succeeded in
growing diffraction quality crystals of Q258C–RT disul-
fide cross-linked to an RNA:DNA template:primer (H.H,
S.C.H. and G.L.V., unpublished observations).
Stability of disulfide cross-link
A crucial aspect of our intermolecular cross-linking system
is the use of disulfide bond formation, a process that is
rapidly reversible. We were interested to determine how
effective the RT–DNA cross-link is at competing with
free thiols in solution under equilibrating conditions. To
address this issue, we carried out cross-linking reactions in
the presence of increasing concentrations of the potent
reducing agent dithiothreitol (DTT), in addition to the
usual fixed amount (2 mM) of β-mercaptoethanol. After
allowing the reaction to proceed for 2 hours at room tem-
perature, it was quenched by adding a rapid thiol-capping
agent. The extent of cross-linking was determined by
nonreducing SDS–PAGE analysis (Figure 4c). Remark-
ably, the disulfide cross-linking of RT to its duplex sub-
strates takes place to an appreciable extent even in the
presence of 10 mM DTT, conditions that are generally
considered to maintain proteins in the fully reduced state.
These findings are all the more striking when taking into
account the fact that the 10 mM DTT represents a
1000-fold molar excess over template:primer (10 µM), and
a 2500-fold molar excess over RT (4 µM). It is clear, there-
fore, that the high local concentration of reacting partners
afforded by the noncovalent association of RT with the
template:primer provides a powerful thermodynamic
driving force for the disulfide cross-linking reaction.
Effect of the disulfide cross-linking on the structure of the
RT•DNA duplex
The sensitivity of disulfide cross-link to geometric factors,
together with the robustness of the bond thus formed,
suggested that the cross-linking itself was comfortably
accommodated in the RT•template:primer structure. To
gain direct insight into this issue, we examined the cross-
linked co-crystal structure carefully in the region around
the covalent connection. Despite clear electron density for
helix H and the DNA base pairs in the immediate vicinity
of the cross-link, density for the disulfide linker itself is
absent from 2Fo–Fc maps contoured at 1.2 σ (Figure 5,
cyan), suggesting that the linker is significantly more
mobile that its surroundings. Discontinuous electron
density attributable to the disulfide linker could be
observed in difference electron density maps (Fo–Fc) of
the complex (Figure 5, purple). The distance between the
terminal carbons of the tether in the crystal structure,
~4.8 Å, is less than the maximum calculated distance of
~7.5 Å for an unstrained tether, suggesting that the tether
fits comfortably into the space between RT and DNA.
Furthermore, the segment of helix H and the DNA base
pairs in the immediate vicinity of the cross-link exhibit
normal structural parameters. Taken together, these fea-
tures strongly support the notion that the cross-link exerts
little if any effect on the structure of the RT–DNA–
dNTP complex, but merely acts to prevent dissociation of
the components from one another.
The co-crystal structure of the RT–DNA–dNTP complex
provides a clear rationale for the observed positional speci-
ficity of disulfide cross-linking. As shown in Figure 6, the
α carbons of positions 258, 262 and 266 lie in nearly the
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Figure 5
2Fo–Fc (cyan) and Fo–Fc (purple) electron density maps at 3.2 Å
resolution of the region surrounding the tethered G•C base pair in
template:primer and Cys258 residue in helix H of RT. The maps were
contoured at 1.2 σ (2Fo–Fc) and +3 σ (Fo–Fc), respectively. Oxygen
atoms, red; nitrogen, blue; phosphorus, purple. The terminal atoms of
the disulfide tether (Cys258 β-C and guanine N2-C) and the distance
separating them are shown explicitly; N2-C was not included explicitly
in the structure refinement, but was modeled here by reference to the
positions of other atoms in the G base. The figure was prepared using
Bobscript, a modification of Molscript [32].
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same plane as the 6th, 5th and 4th base pairs from the
dTTP:dA pair bound in the enzyme active site. Even
though an α helix rises much more steeply than base pairs
in A-form DNA (~5.4 Å axial rise per helical turn versus
~3 Å per base pair), the tilt of helix H that permits it to
track the minor groove also creates a near-perfect corre-
spondence of successive α-helical turns with successive
base pairs in the DNA. Based on the structure, it can be
predicted that transposition of the cysteine residue by one
turn on helix H should decrease by one base pair the
optimal distance from the cross-link to the active site (refer
to Figure 3b). Indeed, this is precisely what is observed:
transposition of the cysteine residue from position 258→
262→266 systematically reduces the cross-link–active-site
distance from 6→5→4 base pairs (+3→+2→+1 nucleotides
incorporated for optimal cross-linking; refer to Figure 3b).
The efficiency and selectivity of cross-linking for each of
these three positions are not identical, owing to subtle dif-
ferences in geometric factors, such as DNA conformation
or placement of the cysteine on the face of helix H, which
exerts an influence on the cross-linking chemistry.
Discussion
The inability to obtain high quality co-crystals remains a
major impediment to many studies of protein–nucleic acid
interactions. An especially compelling example of this is
HIV-RT, for which the lack of structural information on a
catalytically relevant complex impeded understanding of
drug resistance mutations and held back efforts to create
novel inhibitors. The work reported here began with
efforts to discover the reason for the failure of RT to co-
crystallize with a template:primer and a nucleotide
triphosphate, and then, on the basis of this information,
turned to design of a system more predisposed toward
crystallization. The present results point to the probable
cause of the failure to grow co-crystals by conventional
methods: RT exhibits only a 6–10-fold preference for a
template:primer containing a polymerizable end over one
that is incapable of being polymerized, even in the pres-
ence of a cognate nucleotide. Remarkably, no preference
whatsoever for substrate versus nonsubstrate template:
primer was observed in the absence of nucleotide (this
work and [26]). The level of specificity shown by RT is,
therefore, too low for the formation of a species suffi-
ciently homogenous for crystallization. We imagine that
noncovalent association of RT, template:primer and
nucleotide yields complexes that differ in the positioning
of the enzyme on the template:primer, and that these
various complexes interconvert on the crystallization
timescale. This analysis led us to the hypothesis that the
RT crystallization problem might be solved by finding a
way to funnel the equilibrating complexes into the single
catalytically relevant one, which would be rendered inca-
pable of dissociation. We have previously reported the use
of disulfide cross-linking to obtain crystals of a ternary
catalytic RT complex [15]; here we have explained in
greater detail the chemistry of this cross-linking reaction,
with an eye toward providing a robust basis for comparison
in future studies with other proteins.
The combinatorial cross-linking system analyzed here has
allowed us to explore independently the influence of
several variables on the rate of the cross-linking reaction:
the distance between the cross-link attachment points in
the protein and template:primer; the length of the cross-
link itself; and the nucleic acid composition (DNA:DNA
or RNA:DNA) of the template:primer. As previously
observed, the cross-linking reaction exhibits tremendous
selectivity for the distance between the enzyme active site
and the location of the cross-link. For example,
Q258C-RT strongly prefers to cross-link a tethered G
residue located on the template strand six base pairs away
from the nucleotide bound in the active site (corresponds
to +3 in Figure 3b, top left-hand panel). The co-crystal
structure of the cross-linked RT catalytic complex clearly
shows that in this configuration, the cross-linking partners
are nearer to each other than any other register (Figure 6).
The structure also provides a clear explanation for the
positional dependence of the three cysteine RT mutants,
in which the site of cross-linking is scanned along the
helix exposed to the minor groove (Figure 6). Helix H is
tilted in such a way that successive turns are almost per-
fectly aligned with successive base pairs in the
template:primer. Residue 266 therefore lies one base pair
closer to the active site than residue 262, which in turn is
one base pair closer than residue 258. Correspondingly,
W266C-RT requires the addition of one less nucleotide
than G262C-RT for optimal cross-linking, and G262
requires one less than Q258C. Nevertheless, the three
mutants differ clearly in the extent of their positional
selectivity. Whereas Q258C-RT shows nearly perfect in
cross-linking to G(–3), the G262C and W266C mutants are
less selective (compare the number of bands along the
p66•DNA position in Figure 3b). We attribute these dif-
ferences in selectivity to two factors: because the period of
an α helix is nonintegral (3.6 residues/turn), the sidechains
of 258, 262 and 266 are slightly displaced with respect to
one another along the face of helix H; and helix H lies
over a segment of the template:primer that is in transition
from A-form (carboxy-terminal end of helix H) to B-form
(amino-terminal end of helix H). The local DNA confor-
mation with respect to the cysteine sidechain is, therefore,
subtly but significantly different at positions 258, 262 and
266. The minor cross-link bands represent RT•template:
primer complexes in which the cysteine residue is dis-
placed by one base pair from that containing the thiol
tether, suggesting there is enough play in the cross-link to
reach one base pair away. This conclusion is consistent
with the results of the X-ray analysis (Figure 5), which
shows that the cross-link itself is conformationally mobile
and several angstroms longer than the shortest cross-
linking distance.
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Many proteins require external thiol to maintain their
activity. Can disulfide cross-linking, which usually
requires oxidizing conditions, be applied in such cases?
We show here that the disulfide cross-linking of RT to
template:primer is surprisingly efficient under conditions
that are sufficiently reducing to keep most proteins active.
This result presumably reflects the fact that the noncova-
lent binding of RT to DNA causes the reacting partners to
be present in a high effective concentration, thereby pro-
viding thermodynamic driving force for the overall reac-
tion. In a chemical sense, this is equivalent to disulfide
formation during protein folding, where protein–protein
interactions drive the formation of thermodynamically
stable disulfide bonds. It is also analogous to the high
reduction potential of protein thioredoxin [27], wherein
two cysteines are closely juxtaposed in a β-turn structure.
Another serious concern in any cross-linking study is the
trapping of strained species. The ability to do disulfide
chemistry under conditions in which disulfides are freely
exchanging enables the preferential trapping of a stable
complex. The structure of the cross-linked RT•DNA
complex bears out this expectation. Specifically, the posi-
tional selectivity of the cross-linking reaction corresponds
to the product with the most relaxed structure. Further-
more, the tether itself is unstrained and conformationally
mobile. The lack of cross-linking-induced structural per-
turbation is also clearly evident in the X-ray structure.
Both the helix H and the DNA near the cross-link attach-
ment points are virtually superimposible on the corre-
sponding elements of the noncatalytic, noncovalent
RT•DNA complex.
These studies provide a blueprint for the use of disulfide
cross-links to freeze protein–DNA complexes for struc-
tural studies. From a practical point of view, use of this
method is facilitated by having some notion of amino acid
residues that are likely to lie near the DNA. Indeed, for
the reasons described above, formation of a stable cross-
link itself constitutes strong evidence for the residue in
question being located near DNA in the non-cross-linked
state. The method can therefore be used to test hypothe-
ses concerning the location of particular residues at the
protein–DNA interface, in cases where the body of avail-
able structural information is insufficiently predictive. For
reasons particular to the case of RT•template:primer
complex, we chose to attach the enzyme to a G residue in
the minor groove. In other cases, it may be advantageous
to link the protein to some other portion of the DNA or
RNA, such as a base in the major groove or the backbone.
There exist many straightforward methods for incorporat-
ing thiols into nearly any position in DNA
[20–22,25,28,29], and the required reagents are in many
instances commercially available. We recommend the use
of a screening approach akin to that employed here, to
sample multiple cross-link configurations and to deter-
mine experimentally the one that is most stable and most
likely to be physiologically relevant.
Significance
Many protein–nucleic acid interacting systems are diffi-
cult to study using high-resolution structural methods
because they do not form stable homogenous complexes.
We have shown that this is the case for HIV-1 reverse
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Figure 6
Ribbon representation of (a) front and
(b) side views of the location of helix H
relative to template:primer in the RT–DNA
crystal structure. Relevant bases are color-
coded as in Figure 3, and the backbone of
the template:primer is in gray. α Carbons of
the mutated cysteine residues (blue)
examined biochemically in helix H (gold) are
highlighted to illustrate the relative positions
of these amino acids to the surrounding base
pairs. N2 of thiol tethered dG is colored as a
magenta sphere to illustrate its location
relative to the α carbon of residue 258. Dash
denotes the cross-linked positions in the
crystallographically determined complex. The
figure was prepared using RIBBONS [33].
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transcriptase, which binds a polymerizable substrate
only 6–10-fold more tightly than a nonpolymerizable
substrate. Based on these observations, we formulated a
strategy to freeze a catalytically relevant reverse tran-
scriptase (RT)–DNA complex through equilibrium
disulfide cross-linking. We have analyzed in detail a
number of key parameters to understand their influence
on the cross-linking reaction: relative positions of the
tether in the template:primer and protein, length of the
tether, DNA:DNA versus RNA:DNA template:primer
and competition by external thiols. These studies
provide a blueprint for the application of disulfide cross-
linking techniques to other protein–nucleic acid systems.
Materials and methods
Materials
T4 polynucleotide kinase, restriction endonucleases and DNA poly-
merases were from New England Biolabs. Nucleoside triphosphates
were from Sigma. [γ-32P] ATP was from DuPont/New England Nuclear
Corp. Ni-NTA resin was from Qiagen. SE-Sepharose resin and
Superdex 75 size exclusion column were from Pharmacia. All other
reagents were of the highest quality commercially available.
Construction, expression and purification of HIV-1 RT
The coding sequences for both p66 and p51 of RT (amplified by poly-
merase chain reaction (PCR) from plasmid pRT66/51, a generous gift
from R.S. Goody [30]), each linked to an independent T7 promoter,
were introduced into the plasmid pLM1 [16,17]. Site-directed PCR
mutagenesis was used to mutate Glu478 in the RNase H domain of
p66 subunit to glutamine, with the aim of eliminating RNase H catalytic
activity so that studies on RNA:DNA hybrids can be carried out [31].
Pro1 was also mutated to lysine to increase the expression level of RT
in E. coli. For purposes of disulfide cross-linking studies, three residues
on helix H of p66 — Gln258, Gly262 and Trp266 — were individually
mutated to cysteine. In addition to the helix H mutation, each of the
variant proteins used in this study contained the Cys280→Ser muta-
tion introduced in prior crystallographic studies on RT [8]. Overall, each
of the three variant RT proteins contains four cysteine residues — the
one introduced in helix H, the remaining one present in wild-type p66
(C38), and both wild-type cysteine residues in p51 (Cys38 and
Cys280). Recombinant RT enzymes were expressed in E. coli BL21
(DE3). The enzymes were purified to high homogeneity by a sequence
of chromatography steps on Ni-NTA, SE-Sepharose, and Superdex 75.
The fractions containing RT from the last step of purification were
pooled, exchanged in a buffer containing 50 mM Tris–HCl (pH 7.4),
50 mM NaCl, 1 mM EDTA, 30% glycerol, flash frozen in liquid nitrogen,
and stored at –78°C freezer. The protein concentration of purified RT
was measured by UV absorbance at 280 nm using an extinction coeffi-
cient ε280 = 266,800 M–1 cm–1.
Synthetic oligonucleotides
DNA and RNA oligonucleotides were synthesized on an Applied
Biosystems 392 DNA/RNA synthesizer. For modified oligonucleotides,
the thiol tether was introduced into the template:primer through post-
synthetic modification using the convertible nucleoside approach [25].
Cystamine deprotection gave the C2 tether protected as the mixed
2-aminoethyl disulfide, and 3-aminopropane disulfide deprotection
gave the C3 tether. Both modified and unmodified oligonucleotides
were purified using denaturing polyacrylamide gel electrophoresis
(15% acrylamide, 8 M urea). Concentrations of the oligonucleotides
were estimated by UV at 260 nm. For EMSAs, the template strand of
DNA substrate was labeled at the 5′ end using T4 polynucleotide
kinase and [γ-32P] ATP according to the directions of the manufacturer.
The duplex was formed by mixing complementary strands in a molar
ratio of 1:1.05 (the radiolabeled or modified strand is the limiting one)
or 1:1 (competitor DNA in EMSAs) in a buffer containing 10 mM
Tris–HCl (pH 7.4), 10 mM NaCl. The mixed sample was heated to
70°C for 5 min, then cooled slowly to room temperature.
Electrophoretic mobility shift assay
DNA substrate was mixed with RT in Reaction buffer containing 50 mM
Tris–HCl (pH 7.4), 25 mM NaCl, 25 mM KCl, 5 mM MgCl2, 5% glycerol,
with or without ddCTP. After 15 min, the competitor DNA was added to
the mixture. The resulting sample was further incubated for an additional
50 min. The mixture was loaded onto a nondenaturing 5% polyacry-
lamide gel (20 × 16 cm). The gel was run at room temperature at 150 V
until the bromophenol blue dye reached 4.2 cm from the bottom of the
gel. The gel was dried and exposed to X-ray film for autoradiography.
Cross-linking reaction and analysis
For a typical cross-linking reaction, the mutant RT enzyme (4 µM) was
mixed together with the thiol-tethered template:primer (10 µM) and a
dNTP/ddNTP cocktail (100 µM each, refer to Figure 3a) in Reaction
buffer (see above) and 2 mM β-mercaptoethanol, which was added to
increase the specificity of cross-linking. Following incubation at 25°C,
the cross-linking reaction was quenched by adding a thiol-capping
reagent, methyl methanethiolsulfonate (20 mM). In experiments analyz-
ing disulfide stability, measured amounts of DTT were added to the
reaction mixture, and the concentration of thiol-capping reagent was
elevated to 100 mM to ensure complete capping of all the free thiol
groups in the reaction mixture. SDS loading buffer was added to the
quenched reaction mixture. The sample was heated at 90°C for 5 min,
and analyzed by SDS–PAGE (15% acryamide) under nonreducing
conditions. The gel was stained in Coomassie blue solution overnight.
Purification of RT•template:primer complex
The cross-linking reaction was carried out on a preparative scale.
Q258C-RT (133 µM in 75 µl storage buffer) was mixed together with
an equimolar amount of the thiol-tethered template:primer in 50 µl TE
buffer. Rather than elongate the primer by carrying out three cycles of
polymerization as shown in Figure 3c, we included the first two bases
in the primer strand, and carried out only one cycle of polymerization,
adding a ddA residue to the 3′-end of the primer strand, (dTTP is
included to bind noncovalently in the enzyme active site). The final
product is identical to that produced by three cycles of polymerization
(Figure 3c). Thus, to the Q258C-RT and template:primer mixture was
added 50 µl of a nucleotide cocktail containing 2 mM of each ddATP
and dTTP, 100 µl 5× Reaction buffer plus 2 mM β-mercaptoethanol.
The final volume of the reaction was adjusted to 500 µl by the addition
of TE buffer. Following 1.5 days of incubation at 25°C, the reaction
mixture was diluted to 1.5 ml with elution buffer A (10 mM NaCl,
20 mM Tris.HCl, pH 8.0), and loaded into an anion-exchange column
(Pharmacia, 0.5 × 5 cm). The covalent complex was eluted using NaCl
gradient (10 mM to 1000 mM) in a buffer containing 20 mM Tris.HCl
(pH 8.0) at the concentration of NaCl 350 mM. The sample was col-
lected, exchanged twice with a exchanging buffer (10 mM MES,
pH 6.5, 2 mM MgCl2, 200 mM NaCl, 0.05 mM EDTA, 0.5 mM dTTP),
and concentrated. More dTTP was added to the concentrated sample
so that the final concentration of dTTP and complex is 2 mM and
8 mg/ml, respectively. The complex was used directly in crystallization
trials, the details of which have been reported elsewhere [15].
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